Trial record 1 of 1 for: NCT01202188
Previous Study | Return to List | Next Study
A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (SHINE)
This study has been completed.
First Posted: September 15, 2010
Last Update Posted: September 9, 2013
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )